Cargando…
The inhibitory effect of anti-allergic agent suplatast tosilate (IPD-1151T) on methacholine- and allergen-induced bronchoconstriction in sensitized mice. asakazu@med.showa-u.dc.jp.
The influence of an anti-allergic agent, suplatast tosilate (IPD-1151T; (+/-)-[2-[4-(3-ethoxy-2-hydroxypropoxy)phenyl-carbamoyl]-ethyl] dimethylsulfonium p-toluenesulfonate) on allergic bronchoconstriction induced by allergen and methacholine (MCh) were examined in mice. BALB/c mice were sensitized...
Autores principales: | Asano, K, Mizutani, T, Shimane, T, Hisano, M, Hisamitsu, T, Suzaki, H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781752/ https://www.ncbi.nlm.nih.gov/pubmed/10958380 |
Ejemplares similares
-
Suppressive effects of anti-allergic agent suplatast tosilate (IPD-1151T) on the expression of co-stimulatory molecules on mouse splenocytes in vivo.
por: Kurokawa, M, et al.
Publicado: (2001) -
Case of Eosinophilic Cystitis Treated with Suplatast Tosilate as Maintenance Therapy
por: Yoshino, Tateki, et al.
Publicado: (2012) -
Effectiveness of a combination of cyclosporine A, suplatast tosilate and prednisolone on periodic oscillating hypereosinophilia
por: Imashuku, Shinsaku, et al.
Publicado: (2011) -
Assessment of Bronchodilator Responsiveness after Methacholine-Induced Bronchoconstriction
por: Suh, Dong In, et al.
Publicado: (2011) -
Suplatast Tosilate and Eicosapentaenoic Acid as a Possible Strategy for Maintaining Remission in Minimal Change Nephrotic Syndrome: A Case Report
por: Shichijo, Ayako Y, et al.
Publicado: (2023)